Isotype and IgG Subclass Distribution of Autoantibody Response to Alpha-enolase Protein in Adult Patients with Severe Asthma
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: A possible involvement of autoimmune mechanism in the pathogenesis of bronchial asthma has been proposed. Recently, alpha-enolase protein was identified as a major autoantigen recognized by circulating IgG autoantibodies in patients with severe asthma. To evaluate a possible pathogenetic significance of these autoantibodies in severe asthma, isotype (IgG, IgA, IgM, and IgE) and IgG subclass (IgG1, IgG2, IgG3, and IgG4) distributions of autoantibodies to recombinant human alpha-enolase protein were analyzed. Patients and Methods: We examined serum samples from 10 patients with severe asthma and 7 patients with mild-to-moderate asthma, and 5 healthy controls by immunoblot analysis. Severe asthma was defined as patients having at least 1 severe asthmatic exacerbation requiring an emergency department visit or admission in the last year despite continuous typical therapies. Results: IgG1 was the predominant IgG subclass antibody response to alpha-enolase protein in patients with severe asthma. IgG1 autoantibody to alpha-enolase protein was detected in 7 of 10 patients with severe asthma (70%), 1 of 7 patients with mild-to-moderate asthma (14.3%), and none of 5 healthy controls (0%) (chi-square test; p<0.05). IgA, IgM, and IgE autoantibodies to alpha-enolase protein could not be detected in patients with severe asthma. Conclusion: IgG1 subclass was the predominant type of autoantibody response to alpha-enolase protein in patients with severe asthma, suggests a possibility of IgG1 autoantibody-mediated complement activation in the pathogenesis of severe asthma.
Abstract
Purpose: A possible involvement of autoimmune mechanism in the pathogenesis of bronchial asthma has been proposed. Recently, alpha-enolase protein was identified as a major autoantigen recognized by circulating IgG autoantibodies in patients with severe asthma. To evaluate a possible pathogenetic significance of these autoantibodies in severe asthma, isotype (IgG, IgA, IgM, and IgE) and IgG subclass (IgG1, IgG2, IgG3, and IgG4) distributions of autoantibodies to recombinant human alpha-enolase protein were analyzed. Patients and Methods: We examined serum samples from 10 patients with severe asthma and 7 patients with mild-to-moderate asthma, and 5 healthy controls by immunoblot analysis. Severe asthma was defined as patients having at least 1 severe asthmatic exacerbation requiring an emergency department visit or admission in the last year despite continuous typical therapies. Results: IgG1 was the predominant IgG subclass antibody response to alpha-enolase protein in patients with severe asthma. IgG1 autoantibody to alpha-enolase protein was detected in 7 of 10 patients with severe asthma (70%), 1 of 7 patients with mild-to-moderate asthma (14.3%), and none of 5 healthy controls (0%) (chi-square test; p<0.05). IgA, IgM, and IgE autoantibodies to alpha-enolase protein could not be detected in patients with severe asthma. Conclusion: IgG1 subclass was the predominant type of autoantibody response to alpha-enolase protein in patients with severe asthma, suggests a possibility of IgG1 autoantibody-mediated complement activation in the pathogenesis of severe asthma.
참고문헌 (26)
- Mechanisms of asthma, "Global Initiative for Asthma: Global strategy for asthma management and prevention", pp.50~66 (2002), National Institutes of Health
- The ENFUMOSA study group, "The ENFUMOSA crosssectional European multicentre study of the clinical phenotype of chronic severe asthma", Eur Respir J, 22, pp.470~477 (2003)
- Busse WW, "Pathophysiology of severe asthma", J Allergy Clin Immunol, 106, pp.1033~1042 (2000)
- Rottem M, "Asthma as a paradigm for autoimmune disease", Int Arch Allergy Immunol, 132, pp.210~214 (2003)
- Virchow JC Jr, "Inflammatory determinants of asthma severity: mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma", J Allergy Clin Immunol, 98, pp.s27~s33 (1996)
- Wagner V, "Autoimmune mechanism in diseases of the respiratory tract", Acta Allergol, 20, pp.1~9 (1965)
- Nahm DH, "Identification of cytokeratin 18 as a bronchial epithelial autoantigen associated with nonallergic asthma", Am J Respir Crit Care Med, 165, pp.1536~1539 (2002)
- Lassalle P, "T and B cell immune response to a 55-kDa endothelial cell-derived antigen in severe asthma", Eur J Immunol, 23, pp.796~803 (1993)
- Dekker JW, "Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes", Clin Exp Allergy, 27, pp.574~577 (1997)
- Kero J, "Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study", J Allergy Clin Immunol, 108, pp.781~783 (2001)
- Holgate ST, "Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease", Cytokine, 28, pp.152~157 (2004)
- Kon OM, "Anti-T cell strategies in asthma", Inflamm Res, 48, pp.516~523 (1999)
- Nahm DH, "Identification of alpha-enolase as an autoantigen associated with severe asthma", J Allergy Clin Immunol, 118, pp.376~381 (2006)
- Lee KH, "Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease", Arthritis Rheum, 48, pp.2025~2035 (2003)
- Nahm DH, "Analysis of induced sputum for studying allergen-specific IgE antibodies in airway secretion from asthmatic patients", Clin Exp Allergy, 28, pp.686~693 (1998)
- Paul S, "Characterization of autoantibodies to vasoactive intestinal peptide in asthma", J Neuroimmunol, 23, pp.133~142 (1989)
- Terrier B, "Alpha-enolase: a target of antibodies in infectious and autoimmune diseases", Autoimmun Rev, 6, pp.176~182 (2007)
- Girard JP, "Antigenic properties of lung tissue. Presence of specific antibodies in certain chronic respiratory disorders", Poumon Coeur, 29, pp.267~270 (1973)
- Szczeklik A, "Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance", Am J Respir Crit Care Med, 152, pp.1753~1756 (1995)
- Lee SH, "Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma", Am J Respir Crit Care Med, 173, pp.370~378 (2006)
- Wills-Karp M, "New insights into the role of the complement pathway in allergy and asthma", Curr Allergy Asthma Rep, 5, pp.362~369 (2005)
- Callerame ML, "Immunologic reactions of bronchial tissues in asthma", N Engl J Med, 284, pp.459~464 (1971)
- Fregonese L, "Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma", J Allergy Clin Immunol, 115, pp.1148~1154 (2005)
- Wakui H, "Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN)", Clin Exp Immunol, 118, pp.445~450 (1999)
- Holdsworth SR, "Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis", Kidney Int, 55, pp.1198~1216 (1999)
- Jenmalm MC, "Allergen-induced cytokine secretion in relation to atopic symptoms and immunoglobulin E and immunoglobulin G subclass antibody responses", Pediatr Allergy Immunol, 10, pp.168~177 (1999)